In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Stada plans to buy Russian Rx co Nizhpharm

Executive Summary

Stada Arzneimittel AG (generics and branded and specialty drugs based on off-patent active ingredients) has signed a provisional agreement to acquire Nizhpharm JSC, one of Russia's top three or four pharmaceutical companies, for €80-85mm ($101-108mm).
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Preliminary
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies